Observational studyEye (London, England)2026

Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD study.

James Talks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.